02/12/2013
https://congress.gov...
"I believe that all of us assembled here, both those of us on the Committee and our assembled panel of witnesses, recognize that technology often evolves much faster than the law."
"And so is it fair to conclude that your assessment is that the transparency related to your relationship with the pharmaceutical company, that it could produce higher costs for the consumer?"
"the ability to at least have some bargaining power against these pharmaceutical companies in the marketplace is something that we should attempt to preserve as much as we can."
"Mr. Balto argues in his written testimony that there is an 'increasing disregard of the antitrust laws in the pharmaceutical area' and argues as a result that 'consumers suffer from a lack of choice i..."